WinstonWınston
Back
Cigna Corporation logo

Cigna Corporation

CGN.DE
50
Medical - Healthcare Plans · Healthcare
Price
€237.10
+1.65 (+0.70%)
Market Cap
€62.65B
Exchange
Frankfurt Stock Exchange
Winston Score
50
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Good
Growth
Good
Cash Flow
Strong
Stability
Good
Valuation
Strong
Dividends
Mixed

Share count falling — buybacks

32.9% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 341.0M (2021) → 228.7M (2025)

Winston Score History

The full picture

Cigna is a large American health insurance and benefits company. It sells medical, dental, vision, and behavioral health insurance plans to employers, governments, and individuals. Cigna also owns Express Scripts, one of the largest pharmacy benefit managers in the United States, which processes prescription drug claims for millions of people.

Cigna makes most of its money by collecting premiums from customers and then paying out medical claims, keeping the difference. It also earns fees for managing pharmacy benefits through Express Scripts. The company operates mainly in the United States but has some international health and life insurance businesses. Its pharmacy benefit management arm gives it scale advantages in negotiating drug prices, which acts as a competitive moat. The main risk Cigna faces is rising medical costs — if healthcare utilization increases faster than premiums, profit margins can shrink quickly, as the industry broadly experienced in 2024.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
100.0%
Premium pricing power — 100.0% gross margin
Profit after running costs
Operating Margin
0.0%
Thin — 0.0% operating margin
Return on the money invested
ROCE
10.2%
Below par — 10.2% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-12.5%
Shrinking sales (-12.5% YoY)
Profit growth
EPS YoY
+45.8%
Earnings growing fast (+45.8% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
142%
Turns 142% of profit into real cash
Spare cash per sale
FCF Margin
3.5%
Thin free cash flow (3.5%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.73
Moderate — manageable debt (0.73)
Covers its interest
Interest Cover
6.52x
Adequate interest coverage (6.5x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
9.5x
Attractive valuation — P/E 9.5

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year
P/E vs Forward
+1.9
GROWING
Earnings expected to grow — slightly cheaper on forward P/E

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
2.18%
Moderate income — 2.18% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
-0.2%
Dividend cut (-0.2% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial